Veterinary Research Forum
Vet Res Forum

Susceptibility of Pasteurella multocida isolated from cattle in Egypt to antibiotics, silver, chitosan and curcumin nanoparticles

Document Type : Original Article

Authors

Amany Dieb Bahr
Emil Saad Abdel Massieh

Department of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt

https://doi.org/10.30466/vrf.2024.2017140.4090
Abstract
Pasteurella multocida is a Gram-negative bacterium causing economically significant diseases in cattle. This study aimed to determine P. multocida susceptibility to different antibiotics and antibiotic alternatives. In this study, 246 samples (180 nasal swabs and 66 lung tissue specimens) were collected from cattle showing respiratory manifestations in Egypt. Suspected P. multocida colonies following culture were subjected to polymerase chain reaction (PCR) for molecular confirmation of the isolates. A multiplex PCR was employed to identify P. multocida capsular groups. Susceptibility of the isolated P. multocida to different antibiotics and nanoparticles as antibiotic alternatives including silver (AgNPs), chitosan (CNPs) and curcumin (CurNPs) were tested using broth microdilution method. Thirty-two P. multocida isolates were obtained, kmt1 gene was detected in these isolates, and molecular capsular types classification revealed that all isolates were belonged to the capsular type A. Based on broth microdilution method findings, 20 (62.50%) isolates were considered as multi-drug resistant (MDR); the isolates were most sensitive to danofloxacin and kanamycin, whereas they were most resistant to doxycycline and tilmicosin. Antibiotic alternatives showed high anti-microbial activity against tested isolates with minimum inhibitory concentrations ranging from 1.56 - 6.25 μg mL-1, 156 - 625 μg mL-1, and 128 - 512 μg mL-1 for AgNPs, CNPs and CurNPs, respectively. Our finding demonstrated that MDR P. multocida was evident in cattle in Egypt. Although antibiotic alternatives showed promising in vitro anti-microbial effects against MDR isolates, additional studies are required to be actually applicable in veterinary practices.

Keywords

Antibiotic susceptibility
Multi-drug resistance
Nanoparticles antibiotic alternatives
Pasteurella multocida

Subjects

  1. Kabeta T, Fikadu T, Zenebe T, et al. Review on the pneumonic pasteurellosis of cattle. AJAD 2015; 4(3): 177-184.
  2. Dabo SM, Taylor JD, Confer AW. Pasteurella multocida and bovine respiratory disease. Anim Health Res Rev 2007; 8(2): 129-150.
  3. Rawat N, Gilhare VR, Kushwaha KK, et al. Isolation and molecular characterization of Mannheimia haemolytica and Pasteurella multocida associated with pneumonia of goats in Chhattisgarh. Vet World 2019; 12(2): 331-336.
  4. Karimkhani H, Zahraie Salehi T, Sadeghi Zali NH, et al. Isolation of Pasteurella multocida from cows and buffaloes in Urmia's slaughterhouse. Arch Razi Inst 2011; 66(1): 37-41.
  5. Elbatawy RM, El-Mashad ABI, Amin AA, et al. Morphopathological changes of natural pneumonic pasteurellosis in calves. Benha Vet Med J 2022; 41(2): 106-113.
  6. Ferreira TS, Moreno LZ, Felizardo MR, et al. Pheno- and genotypic characterization of Pasteurella multocida isolated from cats, dogs, and rabbits from Brazil. Comp Immunol Microbiol Infect Dis 2016; 45: 48-52.
  7. Petrocchi-Rilo M, Gutiérrez-Martín CB, Pérez-Fernández E, et al. Antimicrobial resistance genes in porcine Pasteurella multocida are not associated with its antimicrobial susceptibility pattern. Antibiotics (Basel) 2020; 9(9): 614. doi: 10.3390/ antibiotics9090614.
  8. Gharibi D, Haji Hajikolae MR, Ghorbanpour M, et al. Isolation, molecular characterization, and antibiotic susceptibility pattern of Pasteurella multocida isolated from cattle and buffalo from Ahwaz, Iran. Arch Razi Inst 2017; 72(2): 93-100.
  9. Watts JL, Sweeney MT, Lubbers BV. Antimicrobial susceptibility testing of bacteria of veterinary origin. Microbiol Spectr 2018; 6(2): doi: 10.1128/ microbiolspec.ARBA-0001-2017.
  10. Ozdal M, Gurkok S. Recent advances in nanoparticles as antibacterial agent. ADMET DMPK 2022; 10(2): 115-129.
  11. Prasher P, Singh M, Mudila H. Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges. 3 Biotech 2018; 8(10): 411. doi: 10.1007/s13205-018-1436-3.
  12. Adahoun MA, Al-Akhras MH, Jaafar MS, et al. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol 2017; 45(1): 98-107.
  13. Alqahtani F, Aleanizy F, El Tahir E, et al. Antibacterial activity of chitosan nanoparticles against pathogenic gonorrhoea. Int J Nanomedicine 2020; 15: 7877-7887.
  14. Shariati A, Asadian E, Fallah F, et al. Evaluation of nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infection in Tehran, Iran. Infect Drug Resist 2019; 12: 2223-2235.
  15. Markey B, Leonard F, Archambault M, et al. Clinical veterinary microbiology, 2nd Missouri, USA: Mosby, Elsevier Health Sciences 2013; 307-316.
  16. Quinn PJ, Leonard FC, Hartigan P, et al. Veterinary microbiology and microbial disease. 2nd New Jersey, USA: Wiley-Blackwell Publishing Ltd. 2002; 137-143.
  17. Townsend KM, Frost AJ, Lee CW, et al. Development of PCR assays for species- and type-specific identification of Pasteurella multocida J Clin Microbiol 1998; 36(4): 1096-1100.
  18. Townsend KM, Boyce JD, Chung JY, et al. Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. J Clin Microbiol 2001; 39(3): 924-929.
  19. Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens 2021; 10(2):165. doi: 10.3390/pathogens10020165.
  20. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 9th ed. In: CLSI Document M07-A9. Wayne. Clinical and Laboratory Standards Institute; 2012.
  21. Sweeney MT, Papich MG, Watts JL. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease. J Vet Diagn Invest 2017; 29(2): 224-227.
  22. Dallas SD, McGee L, Limbago B, et al. Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae. J Clin Microbiol 2013; 51(6): 1798-1802.
  23. Wang Z, Kong LC, Jia BY, et al. Aminoglycoside susceptibility of Pasteurella multocida isolates from bovine respiratory infections in China and mutations in ribosomal protein S5 associated with high-level induced spectinomycin resistance. J Vet Med Sci 2017; 79(10): 1678-1681.
  24. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 3rd ed. In: CLSI supplement VET01S. Wayne; USA: Clinical and Laboratory Standards Institute 2015.
  25. Guzman M, Dille J, Godet S. Synthesis of silver nanoparticles by chemical reduction method and their antibacterial activity. WASET 2008; 2: 91- 98.
  26. Tahamtan Y, Hayati M, Namavari MM. Isolation and identification of Pasteurella multocida by PCR from sheep and goats in Fars province, Iran. Arch Razi Inst 2014; 69(1): 89-93.
  27. Abed AH, El-Seedy FR, Hassan HM, et al. Serotyping, genotyping, and virulence genes characterization of Pasteurella multocida and Mannheimia haemolytica isolates recovered from pneumonic cattle calves in North Upper Egypt. Vet Sci 2020; 7(4): 174. doi: 10.3390/vetsci7040174.
  28. Soriano-Vargas E, Vega-Sánchez V, Zamora-Espinosa JL, et al. Identification of Pasteurella multocida capsular types isolated from rabbits and other domestic animals in Mexico with respiratory diseases. Trop Anim Health Prod 2012; 44(5): 935-937.
  29. Kehrenberg C, Schulze-Tanzil G, Martel JL, et al. Antimicrobial resistance in Pasteurella and Mannheimia: epidemiology and genetic basis. Vet Res 2001; 32(3-4): 323-339.
  30. Coetzee JF, Magstadt DR, Sidhu PK, et al. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples. PLoS One 2019; 14(12): e0219104. doi: 10.1371/journal. pone.0219104.
  31. Xu C, Kong L, Gao H, et al. A review of current bacterial resistance to antibiotics in food animals. Front Microbiol 2022; 13: 822689. doi: 10.3389/fmicb. 2022.822689.
  32. Klima CL, Holman DB, Cook SR, et al. Multidrug resistance in Pasteurellaceae associated with bovine respiratory disease mortalities in North America from 2011 to 2016. Front Microbiol 2020; 11: 606438. doi: 10.3389/fmicb.2020.606438.
  33. Melchner A, van de Berg S, Scuda N, et al. Antimicrobial resistance in isolates from cattle with bovine respiratory disease in Bavaria, Germany. Antibiotics (Basel) 2021; 10(12): 1538. doi: 10.3390/ antibiotics10121538.
  34. Becker J, Perreten V, Steiner A, et al. Antimicrobial susceptibility in coli and Pasteurellaceae at the beginning and at the end of the fattening process in veal calves: comparing 'outdoor veal calf' and conventional operations. Vet Microbiol 2022; 269: 109419. doi: 10.1016/j.vetmic.2022.109419.
  35. Anholt RM, Klima C, Allan N, et al. Antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex in Alberta, Canada. Front Vet Sci 2017; 4: 207. doi: 10.3389/fvets.2017.00207.
  36. Depenbrock S, Aly S, Wenz J, et al. In-vitro antibiotic resistance phenotypes of respiratory and enteric bacterial isolates from weaned dairy heifers in California. PLoS One 2021; 16(11): e0260292. doi: 10.1371/journal.pone.0260292.
  37. Bourély C, Cazeau G, Jouy E, et al. Antimicrobial resistance of Pasteurella multocida isolated from diseased food producing animals and pets. Vet Microbiol 2019; 235: 280-284.
  38. Loo YY, Rukayadi Y, Nor-Khaizura MA, et al. In vitro antimicrobial activity of green synthesized silver nanoparticles against selected gram-negative food-borne pathogens. Front Microbiol 2018; 9: 1555. doi: 10.3389/fmicb.2018.01555.
  39. Liao S, Zhang Y, Pan X, et al. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Int J Nanomedicine 2019; 14: 1469-1487.
  40. Wardani G, Mahmiah, Sudjarwo SA. In vitro antibacterial activity of chitosan nanoparticles against Mycobacterium tuberculosis. Pharmacogn J 2018; 10(1): 162-166.
  41. Bhawana, Basniwal RK, Buttar HS, et al. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem 2011; 59(5): 2056-2061.
Veterinary Research Forum
Volume 15, Issue 9
September 2024
Pages 455-462

  • Receive Date 04 December 2023
  • Revise Date 09 March 2024
  • Accept Date 07 April 2024

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us